Investment
Features
FeesSafety
Academy
More
Pluang+

North Immunology merges with Aethlon, raises $180M to develop NOR-101 for atopic dermatitis.

Company Fundamentals
17 Sep 2026
PRNewsWire
View Source
Bullish
North Immunology merges with Aethlon, raises $180M to develop NOR-101 for atopic dermatitis.

North Immunology and Aethlon Medical have agreed to merge in an all-stock deal, with North Immunology leading the combined company focused on developing NOR-101, a bispecific antibody targeting inflammation in atopic dermatitis. The merger includes an oversubscribed $180 million private placement to fund operations through mid-2028. NOR-101's Phase 1a trial is set to start in early 2027, with further clinical data expected in 2027 and 2028. The combined company will trade on Nasdaq under the ticker NRTX, aiming to advance NOR-101 as a potential best-in-disease treatment for immune and inflammatory diseases.

The merger of Aethlon Medical and North Immunology is the story's subject, here is Pluang's market snapshot for context. Of 91 priced Health-sector US stocks tradable on Pluang, 59 rose and 27 fell today. Notable movers include ASND at USD 239.50 with a 1-day change of -3.31% and Pluang order activity of 91% Sell / 9% Buy, SANA at USD 3.00 with a 1-day change of +2.74% and Pluang order activity of 86% Sell / 14% Buy, and AMWL at USD 13.60 with a 1-day change of +2.03%. This data is as of Sep 17, 2026 17:02 WIB.

More News

ON Semiconductor drives AI and EV growth with new power tech and a 2030 vision despite neutral rating.

ON Semiconductor drives AI and EV growth with new power tech and a 2030 vision despite neutral rating.

ON Semiconductor is focusing on advanced power-density technologies for AI data centers and electric vehicles, aiming for $2.5 billion revenue from AI alone by 2030. Despite a Neutral rating from UBS, the company introduced its Embedded Power Platfor...

Market News
Bearish
39 minutes ago
Salesforce targets $63B revenue by 2030, boosted by new AIforce platform and strong analyst support.

Salesforce targets $63B revenue by 2030, boosted by new AIforce platform and strong analyst support.

Salesforce, a leader in cloud-based CRM software, is driving future growth with its new AIforce platform and ambitious financial goals. The company aims to exceed $63 billion in revenue by 2030, reflecting strong demand for its AI and core software p...

Market News
Bullish
1 hour ago
Oscar Health stock jumps 126% on strong ACA enrollment growth and improved financial outlook

Oscar Health stock jumps 126% on strong ACA enrollment growth and improved financial outlook

Oscar Health's stock has surged 126% this year, driven by a 47% increase in ACA marketplace enrollment despite overall market declines. The company, now the second-largest insurer on the ACA exchange, has raised its earnings outlook and improved its ...

Market News
Bullish
2 hours ago
Cipher Mining stock jumps 10.8% on analyst upgrade and new ERCOT power capacity.

Cipher Mining stock jumps 10.8% on analyst upgrade and new ERCOT power capacity.

Cipher Mining (CIFR) saw its stock rise 10.8% following an Overweight rating and $25 price target from Wells Fargo, implying a 49.5% upside. The boost comes after ERCOT granted 3.2 gigawatts of conditional grid capacity to support Cipher's Bitcoin mi...

Analyst Insights
Bullish
3 hours ago
Wells Fargo rates Hut 8 'Overweight' amid strong crypto mining growth and big institutional buys.

Wells Fargo rates Hut 8 'Overweight' amid strong crypto mining growth and big institutional buys.

Wells Fargo initiated an "Overweight" rating on Hut 8, a cryptocurrency mining and digital infrastructure company, citing strong sector momentum and significant institutional investment. Major investors like California State Teachers Retirement Syste...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App